| 1. |
Nahm CB, Ng K, Lockie P, et al. Focal nodular hyperplasia–a review of myths and truths. J Gastrointest Surg, 2011, 15(12): 2275-2283.
|
| 2. |
Nat L, Poantă LI. Focal nodular hyperplasia (FNH). Rom J Intern Med, 2014, 52(1): 45-49.
|
| 3. |
Hussain SM, Terkivatan T, Zondervan PE, et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics, 2004, 24(1): 3-19.
|
| 4. |
Hanaoka J, Shimada M, Utsunomiya T, et al. Huge focal nodular hyperplasia difficult to distinguish from well-differentiated hepatocellular carcinoma. Hepatol Res, 2012, 42(7): 727-731.
|
| 5. |
Edmondson HA. Tumors of the liver and intrahepatic bile ducts: Atlas of tumors pathology. Section 7. Fascicule 25. Washington DC: Armed Forces Institute of Pathology, 1958: 120.
|
| 6. |
Cristiano A, Dietrich A, Spina JC, et al. Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updates Surg, 2014, 66(1): 9-21.
|
| 7. |
Chandrasegaram MD, Shah A, Chen JW, et al. Oestrogen hormone receptors in focal nodular hyperplasia. HPB (Oxford), 2015, 17(6): 502-507.
|
| 8. |
Luciani A, Kobeiter H, Maison P, et al. Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? Gut, 2002, 50(6): 877-880.
|
| 9. |
Kapp N, Curtis KM. Hormonal contraceptive use among women with liver tumors: a systematic review. Contraception, 2009, 80(4): 387-390.
|
| 10. |
Scheuermann U, Foltys D, Otto G. Focal nodular hyperplasia precedes hepatocellular carcinoma in an adult with congenital absence of the portal vein. Transpl Int, 2012, 25(5): e67-e68.
|
| 11. |
Sato Y, Harada K, Ikeda H, et al. Hepatic stellate cells are activated around central scars of focal nodular hyperplasia of the liver–a potential mechanism of central scar formation. Hum Pathol, 2009, 40(2): 181-188.
|
| 12. |
Cai YR, Gong L, Teng XY, et al. Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma. World J Gastroenterol, 2009, 15(37): 4695-4708.
|
| 13. |
Gong L, Li YH, Su Q, et al. Use of X-chromosome inactivation pattern and laser microdissection to determine the clonal origin of focal nodular hyperplasia of the liver. Pathology, 2009, 41(4): 348-355.
|
| 14. |
Shchyogolev AI, Tumanova UN, Dubova EA. Morphometric evaluation of vascularization of hepatic focal nodular hyperplasia. Bull Exp Biol Med, 2013, 156(2): 266-270.
|
| 15. |
Navarro AP, Gomez D, Lamb CM, et al. Focal nodular hyperplasia: a review of current indications for and outcomes of hepatic resection. HPB (Oxford), 2014, 16(6): 503-511.
|
| 16. |
Ungermann L, Eliás P, Zizka J, et al. Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol, 2007, 63(2): 290-294.
|
| 17. |
Purysko AS, Remer EM, Coppa CP, et al. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. AJR Am J Roentgenol, 2012, 198(1): 115-123.
|
| 18. |
Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology, 2012, 262(2): 520-529.
|
| 19. |
Perrakis A, Demir R, Müller V, et al. Management of the focal nodular hyperplasia of the liver: evaluation of the surgical treatment comparing with observation only. Am J Surg, 2012, 204(5): 689-696.
|
1/5
WeChat